Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • ASCO19 Recap: Caring for Every Patient, Learning from Every Patient

    ASCO19 highlighted a number of immunotherapy developments, including those relating to long-term survival, introducing immunotherapy earlier, biomarkers,…

    June 7, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 5 Update: CAR T Cells for Pleural Cancers and More Melanoma News

    The final day of ASCO19 covered CAR T cells for pleural cancers and long-term updates on several…

    June 5, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 4 Update: Kidney Cancer, Liver Cancer, Stomach Cancer, Esophageal Cancer, and Melanoma

    The fourth day at ASCO19 highlighted immunotherapy strategies for patients with kidney cancer, liver cancer, stomach cancer,…

    June 3, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 3 Update: Immunotherapy for Brain Cancer, Ovarian Cancer, Lung Cancer, and Patients with HIV

    The third day at ASCO19 highlighted immunotherapy strategies for patients with brain cancer, ovarian cancer, lung cancer,…

    June 3, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 2 Update: Biomarkers in Checkpoint Immunotherapy, Targeting Macrophages, and Cellular Immunotherapies

    The second day at ASCO19 highlighted biomarkers that may have value in the context of PD-1 checkpoint…

    June 2, 2019| Arthur N. Brodsky, PhD
  • ASCO19 Day 1 Update: Lung Cancer, Head and Neck Cancer, and the Cost of Immunotherapy

    The opening day at ASCO19 discussed various immunotherapy combinations for head and neck cancer, a bispecific antibody…

    June 1, 2019| Arthur N. Brodsky, PhD
  • Connecting and learning about immunotherapy in San Francisco

    On June 30, 2018, over 200 patients, caregivers, and advocates gathered to connect with experts and learn…

    July 3, 2018| Caroline Offit
  • 30 Days of CRI Impact: How Bacteria and Vaccines Can Help the Immune System Fight Cancer

    This week’s breakthroughs highlight the benefits of bacteria, vaccines, and the use of immunotherapy earlier in the…

    June 30, 2018| Arthur N. Brodsky, PhD
  • Bikes, Beers, and One Cause to Cure All Cancers

    On June 26, 2018, 48 cyclists—CRI Associate Board members, family, and friends—biked together at SWERVE Fitness Flatiron…

    June 29, 2018| Angela Bui
Previous Page
1 2 3 4 5 6
Next Page

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal